1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Marvell Technology completed a $1 billion public offering of 5.300% senior notes maturing April 15, 2036, with net proceeds of about $993.5 million. The company says it will use the proceeds mainly to repay debt, including its 1.650% senior notes due 2026, with any remainder for general corporate purposes such as working capital and share repurchases.
Notes: $1,000,000,000 principal, 5.300% annual interest, paid semi-annually from October 15, 2026, maturing April 15, 2036
Net proceeds of approximately $993.5 million after the underwriters' discount, before other expenses
Proceeds earmarked for repaying debt, including the 1.650% senior notes due 2026
Underwriters bought the notes at 99.235% of principal; Wells Fargo Securities, BofA Securities, J.P. Morgan and Mizuho Securities were representatives
Ecolab entered into a $4.75 billion unsecured delayed draw term loan credit agreement dated April 10, 2026, with Citibank, N.A. as administrative agent. Loan proceeds may only be used to finance the previously announced acquisition of Frigeo Holdings LLC, repay certain Frigeo debt, and pay related fees and expenses, which signals the company is funding that deal with borrowed money.
Facility size: $4.75 billion unsecured committed delayed draw term loan, agreement dated April 10, 2026
Pricing: Term SOFR loans at a margin of 0.75% to 0.875%, depending on Ecolab's credit ratings; ticking fee of 0.06% to 0.08% per annum
Use of proceeds limited to the Frigeo acquisition under the March 20, 2026 merger agreement and related costs
Includes a minimum interest expense coverage ratio covenant tested at the end of each four-quarter period
Integra LifeSciences amended its $150 million accounts receivable securitization facility on April 10, 2026, extending its scheduled termination date to April 10, 2029. The amendments also update customary representations, covenants and receivables concentration limits, and the filing describes them as customary terms.
Facility size is $150 million, originally entered into December 18, 2018, to reduce revolving borrowings and add liquidity.
Amendments dated April 10, 2026 include Amendment No. 8 to the Receivables Financing Agreement and Amendment No. 1 to the Purchase and Sale Agreement.
Scheduled termination date extended to April 10, 2029, with PNC Bank, National Association as Administrative Agent.
Full amendment texts will be filed as exhibits to the Form 10-Q for the quarter ended March 31, 2026.
U.S. Physical Therapy entered a Fourth Amended and Restated Credit Agreement dated April 14, 2026, with Bank of America as administrative agent, providing $450 million in loans. The term loan proceeds will refinance debt under the company's prior Third Amended and Restated Credit Agreement, and the new agreement is secured by substantially all of the company's personal property and guaranteed by its domestic subsidiaries.
Facilities total $450 million: a $275 million five-year revolving facility and a $175 million term loan
Agreement matures April 14, 2031; the term loan proceeds will refinance the Third Amended and Restated Credit Agreement
Term SOFR borrowings carry a margin of 1.25% to 2.25%, based on the consolidated leverage ratio
Company may increase the revolver or add term loans by $125 million plus an unlimited amount, subject to a pro forma leverage ratio not above 2.5:1.0
Flowserve entered a Third Amended and Restated Credit Agreement with Bank of America as administrative agent, replacing its existing credit agreement. The new facility includes a $1,000.0 million unsecured revolver, a term loan of up to $450.0 million, and a maturity date of April 15, 2031; the filing says the proceeds refinance existing debt and fund general corporate purposes. For shareholders, the filing describes a longer maturity and a new set of covenants, including consolidated net leverage and interest coverage requirements.
New $1,000.0 million unsecured revolving credit facility, with an option to increase by up to $400.0 million subject to lender approval
Unsecured term loan of up to $450.0 million; about $450.0 million and about $250.0 million revolver draws made on April 15, 2026
Maturity date for revolving and term loans set at April 15, 2031; interest set at Term SOFR plus 1.375% initially
Existing Second Amended and Restated Credit Agreement dated October 10, 2024 was terminated as part of the refinancing
Federal Realty's operating partnership signed a new $1.4 billion unsecured revolving credit facility on April 14, 2026, replacing its prior $1.25 billion facility that was due April 5, 2027. The new facility matures April 12, 2030, with two six-month extension options, and includes an accordion feature allowing borrowing capacity of up to $2.0 billion. Related term loan agreements were also amended to reflect similar changes.
New $1.4 billion unsecured revolving facility matures April 12, 2030, with two six-month extensions at the partnership's option
Replaces the $1.25 billion facility that had a $310.0 million balance as of December 31, 2025
Initial SOFR margin is 72.5 basis points; accordion option allows expansion up to $2.0 billion
Term loan agreements with PNC Bank and Truist Bank were amended on April 14, 2026
Ford amended several of its credit agreements on April 15, 2026, extending maturities on its main credit facility and revolving facilities and extending the availability of a term loan. The amendments also remove sustainability-linked pricing adjustments, and the filing does not state any new borrowing or drawn amount.
Credit agreement commitments of $3.4 billion (maturing 2028) and $10.1 billion (maturing 2030) extended to April 13, 2029 and April 15, 2031
Supplemental revolving commitments of $2.0 billion extended from April 17, 2028 to April 13, 2029
364-day revolving commitments of $2.5 billion, previously due April 16, 2026, extended to April 14, 2027
Term loan commitments of $3.0 billion now available through December 31, 2026, with any loans maturing December 31, 2028; liquidity covenant requires a minimum of $4 billion
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.